Nycomed US names new CEO

Nycomed has picked Steve Andrzejewski as the company's new CEO. He assumes immediate responsibility for Nycomed US, including manufacturing in Melville and Hicksville, New York, distribution and commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and Savage Laboratories. Nycomed release

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.